My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2017 Remand - PUBLIC NOTICE 3-29-17
>
OnTrack
>
PDT
>
2013
>
PDT 13-1
>
2017 Remand - PUBLIC NOTICE 3-29-17
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
6/29/2017 10:40:50 AM
Creation date
3/29/2017 2:51:35 PM
Metadata
Fields
Template:
PDD_Planning_Development
File Type
PDT
File Year
13
File Sequence Number
1
Application Name
OAKLEIGH COHOUSING
Document Type
Public Notice
Document_Date
3/29/2017
External View
Yes
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
3
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
the testimony submitted during the first open-record period explains how it relates to one (or more) <br />of the tentative planned unit development approval criteria from the Eugene Code (EC) listed below <br />or to another criterion, if a.party believes the following list is incomplete: <br />o <br />EC 9.8320(1) <br />o <br />EC 9.8320(5)(a)(b)(c) <br />o <br />EC 9.8320(6) <br />o <br />EC 9.8320(11)(b) <br />o <br />EC 9.8320(12) <br />o <br />EC 9.6505(3)(b) <br />o <br />EC 9.6870 <br />o <br />EC 9.6835 <br />Second-Open Record Period - <br />When: Received by the City between 5:01 p.m. on April 12, 2017 and 5:00 p.m. on April 26, 2017 <br />Who may submit testimony: Anyone <br />What kind of testimony will be accepted: Written testimony (evidence or argument) that directly <br />responds to testimony received during the first open-record period. Testimony submitted during <br />the second open-record period should specifically identify the earlier testimony to which it <br />responds. <br />Final Open-Record Period <br />When: Received by the City between 5:01 p.m. on April 26, 2017 and 5:00 p.m. on May 3, 2017 <br />Who may submit testimony: Only the applicant (including the applicant's representative) <br />What kind of testimony will be accepted: Written argument (not evidence) directly responding to <br />testimony received during the first and second open-record periods. <br />How to Submit Testimony <br />Any interested person may provide a written statement to the Planning Commission through City Planner <br />Erik Berg-Johansen, via e-mail to erik.bere@ci.eueene.or.us or by mail or hand delivery to <br />Erik Berg-Johansen, City of Eugene Planning Division, 99 West 10th Avenue, Eugene, Oregon 97401 for <br />City receipt within the time frames specified above. Please note that failure to provide statements with <br />sufficient specificity to enable the Planning Commission to respond precludes further appeal based on <br />that testimony. <br />Why is the Planning Commission Accepting Additional Testimony? <br />The City held its original public hearing to consider the Oakleigh Meadow Cohousing development <br />application in 2013. After the City approved the application, the City's approval of the development was <br />appealed through the Oregon court system. Because the City did not give notice of the original hearing to a <br />particular individual, the City was required to hold a second public hearing for that individual, regarding the <br />Oakleigh Meadow Cohousing development application, in 2015. The City's notice of the second (2015) <br />hearing explained that: <br />e At the 2015 hearing, the Planning Commission would accept testimony only from the development <br />applicant and from the individual who did not receive notice in 2013. Other people could not provide <br />testimony to the Planning Commission. <br />The Planning Commission would base its decision on the evidence submitted into the public record <br />during the 2013 process; it would accept only arguments from the applicant and the particular <br />individual who did not receive notice in 2013, and would reject any new evidence about the proposal. <br />
The URL can be used to link to this page
Your browser does not support the video tag.